01_Dipharma Inc_researcher at the new second kilolab line
Successful FDA Inspection at Dipharma Facility in Kalamazoo, MI, USA
07 mai 2024 10h00 HE | Dipharma Francis S.r.l
Dipharma Inc. has been inspected by the US FDA and has received the EIR, satisfactorily closing the inspection process.
Logo DIPHARMA.jpg
Dipharma Receives the 2nd GMP Certification from Brazilian ANVISA
26 oct. 2023 03h59 HE | Dipharma Francis S.r.l
MILAN, Italy, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Dipharma Francis S.r.l. (Dipharma), a leading Contract Development and Manufacturing Organization (CDMO) and a global manufacturer of Active...
Dipharma analytical R&D lab_ Baranzate_Italy
Dipharma expands its Italian R&D Center to increase its analytical services
04 avr. 2023 09h15 HE | Dipharma Francis S.r.l
The Company strengthens its analytical R&D capabilities,to better support its customers operating in the CDMO and Generics market. MILAN, Italy, April 04, 2023 (GLOBE NEWSWIRE) -- Dipharma...
02_Technicians at the new Dipharma CGMP warehouse in the Kalamazoo site
Dipharma completes second phase of CGMP expansion at its Kalamazoo site
10 févr. 2023 10h29 HE | Dipharma Francis S.r.l
MILAN, Italy, Feb. 10, 2023 (GLOBE NEWSWIRE) -- Dipharma Francis S.r.l. (Dipharma), a global CDMO and leading manufacturer of Active Pharmaceutical Ingredients and advanced Intermediates, announced...
Logo DIPHARMA.jpg
Dipharma receives GMP certification from Brazilian ANVISA
01 déc. 2022 08h46 HE | Dipharma Francis S.R.L
MILAN, Italy, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Dipharma Francis S.r.l. (Dipharma), a leading Contract Development and Manufacturing Organization (CDMO) and a global manufacturer of Active...